Acute lymphoblastic leukaemia
Our facility uses the ALL-MB-2008 Protocol to treat ALL in children and young adults. The protocols of the MB group (Moscow-Berlin) were developed under the guidance of Prof. Karachunsky AI with the participation of German specialists specifically for the CIS countries and have already demonstrated their high efficiency (5-year survival rate is 85%). In the Republic of Belarus, the protocols of this group have been used since 2002 (ALL-MB-2002).
An important advantage of this Protocol is the ability to conduct most of the treatment in outpatient settings (in day care units), which makes treatment more comfortable for the patient.
For children who are citizens of the Republic of Belarus, treatment is free of charge. For the convenience of our patients and their parents, 2 specialized children's departments are organized in regional centers (on the basis of the RSPC of radiation medicine and human ecology in Gomel and on the basis of the Mogilev regional children's hospital). All stages of ALLL treatment are performed here (except for cases involving bone marrow and or stem cell transplantation). If necessary, the patient is consulted in the " Republican scientific and practical center of pediatric Oncology, Hematology and immunology.”
For foreign citizens, treatment is provided on a paid basis. The main costs in the treatment of ALL are the costs of medicines, reagents, and consumables. Permanent stay in the hospital is necessary for 1 month from the moment of diagnosis. Further treatment is usually performed on an outpatient basis, which significantly reduces the cost of treatment.
The absence of a language barrier is an important advantage for CIS citizens who are being treated in our center.